new york times run great story much doctors minnesota stumping various atypical antipsychotic meds related large upswing usage though focus article kids quite likely holds true adults well patient gets coverage story anya bailey age apparently developed eating disorder prescribed risperdal i never seen shred evidence support prescription doctor apparently thinking side effect weight gain would bonus case anya developed crippling knot back result treatment mother alleges never told evidence base behind prescription nonexistent authors say nicely highlighting added surprising ms bailey said learning university psychiatrist supervised anya care received johnson johnson risperdal maker return lectures one company drugs doctors including anya bailey maintain payments drug companies influence prescribe patients intersection money medicine effect well patients become one contentious issues health care nowhere true psychiatry increasing payments doctors coincided growing use children relatively new class drugs known atypical antipsychotics best selling drugs including risperdal seroquel zyprexa abilify geodon prescribed half million children united states help parents deal behavior problems despite profound risks almost approved uses minors snip drug maker payments minnesota psychiatrists rose sixfold million years prescriptions antipsychotics children minnesota medicaid program rose ninefold took money makers atypicals tended prescribe drugs children often data suggest average minnesota psychiatrists received least atypical makers appear written three times many atypical prescriptions children psychiatrists received less money key opinion leaders let talk folks quick try new drugs often uses little supporting evidence called high flyers early prescribers well terms docs highly targeted drug companies tend yield highest return investment target docs key opinion leaders find respected physician talk high flyers though docs also targeted use kol seen objective help convince doctor start using new drugs read following snippet company contracts big pharma develop kols influence prescribing habits emphases mine professional networks physicians play important role product adoption decision adopt product profoundly influenced key opinion leader kol peers already formed positive opinion product uniquely created patent pending process target kol focused top prescribers treatments given specialty leaders significantly influence opinions behaviors others knowledge advice enhanced perspective creating advocates help gain adoption product case highly trained engineers delivered solution using latest technology proven process matter weeks successful kol program strategies based systematic rigorous methods identification new research techniques use latest technologies leveraged strategies bms could establish long term relationships mutual trust leaders built integrity continuity user friendly methodology proven successful marketing adoption product requires minimum four steps incorporate four steps basis successful solution awareness physician recognizes product name agreement physician evaluates agrees theoretical premise product adoption physician decides use product trial basis integration physician incorporates product daily practice medicine neat i think see relates remainder nyt article return stumping drug companies nyt piece minnesota psychiatrists collected money drug makers doctors specialty total payments individual psychiatrists ranged median since records incomplete figures probably underestimate doctors actual incomes anya doctor george realmuto gave several educational marketing speeches concerta manufactured johnson johnson also makes risperdal following say i hope misquoted asked gives marketing speeches drugs extent drug useful i want seen leader specialty i involved scientific study said i i wan na key opinion leader money nice said dr realmuto university salary academics get paid much said i entertainer i think i would certainly lot better hey someone fetch me kleenex making per year sign get paid much cry me river blanking credible interview continued dr realmuto said upon reflection payments drug companies probably opened door useless visits drug salesman said would stop giving sponsored lectures future good i saying concerta gig made prescribe risperdal anya case might cozy relationship lead prescribing products perhaps i know concerns me quoted correctly context really thinks k salary enough income case willing put stamp approval drug via marketing speeches k salary insufficient level greed astounding standards moving along drug industry many doctors say promotional lectures provide field invaluable education critics say payments lectures often expensive restaurants disguised kickbacks encourage potentially dangerous drug uses issue particularly important psychiatry mental problems well understood treatment often involves trial error label prescribing common analysis minnesota records shows third minnesota licensed psychiatrists took money drug makers including last eight presidents minnesota psychiatric society psychiatrist receiving drug companies dr annette smick lives outside rochester minn paid drug makers one point dr smick many sponsored talks hard me find time see patients clinical practice said i providing educational benefit i like teaching dr smick said giving many speeches pimping new drugs find time see patients dr smick hereby officially nominated golden goblet award pimpin hard even immediate past president american psychiatric association dr steven sharfstein chimed pointing sure odd lexapro prescribed antidepressant absence evidence better generic antidepressants could lexapro still key opinion leaders talking drug forest labs reps pushing lexapro office visits lexapro featured quite bit medical journal advertising hey think meteoric rise cymbalta might also due marketing rather scientific evidence child adolescent bipolar controversy continues nyt article sudden popularity pediatric bipolar diagnosis coincided shift antidepressants like prozac far expensive atypicals minnesota spent buying antipsychotic drugs atypicals children medicaid cost million fold increase snip many minnesota doctors including president minnesota psychiatric society said drug makers intermediaries paying almost exclusively talk bipolar disorder research regarding treating bipolar children adolescents discussed nyt article study done adolescents took either depakote placebo depakote seroquel combined treatment group better end half adolescents depakote seroquel group dropped study basically study wash yet published paper stated depakote seroquel effective treatment adolescent bipolar mania depakote placebo nice melissa delbello author aforementioned study robert kowatch university cincinatti conducted another study treatment adolescent bipolar seroquel showed equal results perhaps slight advantage depakote delbello kowatch also give marketing talks seroquel doubt considered key opinion leaders studies done safe say evidence base pretty weak treatment child adolescent bipolar disorder data longer term like longer month two treatment sorely lacking one minnesota psychiatrist say regarding meager evidence base child adolescent bipolar time wait prove right said dr kent brockmann psychiatrist twin cities made drug talks one one sales meetings last year leading prescriber atypicals medicaid children wait minute kent brockmann take away one name got guy ha anyway dr brockman needs give kids atypicals urgent maybe buys bipolar children become suicidal line line prescribe new meds urgent urgent emergency makes me wonder docs atypicals ones prescribing neurontin everything well could wait data vindicate prescribing practices turns neurontin psych disorders turned flop stop prescribed like candy many docs maybe i wrong neurontin crowd could entirely different atypicals everything bipolar everywhere crowd i taking guess oh safety food drug administration received reports least children dying least suffering serious side effects antipsychotic listed primary suspect substantial jump least deaths serious side effects among children linked drugs since reporting bad drug effects mostly voluntary numbers likely represent fraction toll summary bipolar diagnosis kids highly controversial pert near evidence favoring treatment using atypical antipsychotics manage bipolar symptoms key opinion leaders done nice job pimping atypicals k many folks earn academia enough provide education colleagues regarding life saving medications drug companies decide push diagnosis recruit kols well utilizing tricks persuade doctors prescribe new meds regardless supporting evidence thank whomever designed law minnesota requiring disclosure industry funding set data regarding industry funding could keep giving thank good folks new york times specifically gardiner harris benedict carey janet roberts insightful piece work note i saying everyone drug sponsored speaking gigs gold chain wearing cane toting pimp i suggesting conflicts interest often influence people even think influenced i openness patients probably aware doctors receiving income side promotion certain medication medications much ask also world people live think k salary insufficient sign entitlement poor money management really rich tastes many mckinnells people think worth anyway hat tip furious seasons